Andrew King is a seasoned pharmaceutical professional with extensive experience in oncology and endocrinology. Currently serving as National Business Director for Oncology at Ipsen since March 2016, Andrew King has held various key roles in the company, including Director of Sales and Associate Director. Prior to Ipsen, Andrew King contributed to Janssen, Pharmaceutical Companies of Johnson and Johnson as Marketing Manager, specializing in vaccines and oncology, and held positions at AstraZeneca Canada, Bayer Pharmaceuticals, and Stryker. Andrew King’s educational background includes a Master of Science in Neuroscience from Western University and a Bachelor of Science in Psychology from Queen's University.
This person is not in any teams
This person is not in any offices